Efficacy of Donepezil in Patients With Chronic Tinnitus
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-12-09
Target enrollment:
Participant gender:
Summary
This study is a prospective, placebo-controlled, randomized, double-blind clinical trial, including 70 patients with chronic sensorineural tinnitus, divided into placebo and treatment groups. Participants received donepezil for 3 months, starting with 5 mg daily for the first month and 10 mg daily for the following two months.